Takara Bio Inc. (TYO: 4974)

Takara Bio Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	44,147	43,505	78,142	67,699	46,086	34,565
Revenue Growth (YoY)	-31.74%	-44.33%	15.43%	46.90%	33.33%	-3.56%
Cost of Revenue	18,138	16,597	33,377	18,488	14,214	13,459
Gross Profit	26,009	26,908	44,765	49,211	31,872	21,106
Selling, General & Admin	16,421	15,615	15,570	14,180	12,357	10,952
Research & Development	7,564	8,324	8,575	6,109	5,545	3,869
Operating Expenses	24,000	23,905	24,224	20,309	17,919	14,830
Operating Income	2,009	3,003	20,541	28,902	13,953	6,276
Interest Expense	-21	-23	-24	-23	-24	-7
Interest & Investment Income	251	186	142	122	113	141
Currency Exchange Gain (Loss)	-61	97	-120	-706	2	-160
Other Non Operating Income (Expenses)	176	140	142	163	115	95
EBT Excluding Unusual Items	2,354	3,403	20,681	28,458	14,159	6,345
Gain (Loss) on Sale of Investments	-	-	-	-	-	-2
Gain (Loss) on Sale of Assets	-345	-344	-97	-168	-98	-31
Asset Writedown	-315	-207	-	-5,227	-517	-880
Other Unusual Items	-2	-	639	4,468	8	-1
Pretax Income	1,692	2,852	21,223	27,531	13,552	5,431
Income Tax Expense	750	1,343	5,176	7,624	3,971	1,601
Earnings From Continuing Operations	942	1,509	16,047	19,907	9,581	3,830
Minority Interest in Earnings	-33	-29	-35	-58	-34	-11
Net Income	909	1,480	16,012	19,849	9,547	3,819
Net Income to Common	909	1,480	16,012	19,849	9,547	3,819
Net Income Growth	-89.38%	-90.76%	-19.33%	107.91%	149.99%	4.43%
Shares Outstanding (Basic)	120	120	120	120	120	120
Shares Outstanding (Diluted)	120	120	120	120	120	120
Shares Change (YoY)	0.00%	-	-	-	-	-
EPS (Basic)	7.55	12.29	132.97	164.84	79.28	31.72
EPS (Diluted)	7.55	12.29	132.97	164.84	79.28	31.72
EPS Growth	-89.38%	-90.76%	-19.33%	107.91%	149.99%	4.43%
Free Cash Flow	3,471	-11,067	31,150	-5,418	5,256	2,356
Free Cash Flow Per Share	28.83	-91.91	258.69	-44.99	43.65	19.57
Dividend Per Share	17.000	17.000	42.000	33.000	16.000	8.000
Dividend Growth	-59.52%	-59.52%	27.27%	106.25%	100.00%	14.29%
Gross Margin	58.91%	61.85%	57.29%	72.69%	69.16%	61.06%
Operating Margin	4.55%	6.90%	26.29%	42.69%	30.28%	18.16%
Profit Margin	2.06%	3.40%	20.49%	29.32%	20.72%	11.05%
Free Cash Flow Margin	7.86%	-25.44%	39.86%	-8.00%	11.40%	6.82%
EBITDA	6,811	8,024	25,276	33,051	17,739	9,806
EBITDA Margin	15.43%	18.44%	32.35%	48.82%	38.49%	28.37%
D&A For EBITDA	4,802	5,021	4,735	4,149	3,786	3,530
EBIT	2,009	3,003	20,541	28,902	13,953	6,276
EBIT Margin	4.55%	6.90%	26.29%	42.69%	30.28%	18.16%
Effective Tax Rate	44.33%	47.09%	24.39%	27.69%	29.30%	29.48%

Source: S&P Capital IQ. Standard template. Financial Sources.